Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Allo-hNHL (FluBuCy)

NCT00785330

Conditions
Disease Attributes, Graft vs Host Disease, Hemic and Lymphatic Diseases, +16 more
Locations
  • Universitätsklinikum Heidelberg Heidelberg, Baden-Würtenberg, Germany
  • Universitätsklinikum Marburg Marburg, Hesse, Germany
  • Universitätsklinikum und Poliklinik Homburg, Saarland, Germany
  • University Hospital Goettingen Göttingen, Germany
View Trial Details
Completed

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

NCT02567656

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope Duarte, California, United States
  • Chao Family Comprehensive Cancer Center University of California Irvine Orange, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View Trial Details
Completed

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

NCT01110733

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • DCH Cancer Treatment Center Tuscaloosa, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Completed

Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)

NCT01839097

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Northeast Georgia Cancer Care, LLC Athens, Georgia, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

NCT00003196

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +87 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • Universitaet Leipzig Leipzig, Germany
View Trial Details
Completed

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

NCT01134341

Conditions
Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions